Diabetic macular edema (DME) is a major factor contributing to visual disabilities in 5 diabetic patients, and the number of patients is increasing. Animal models play a key 6 role in the development of novel therapies. In this study, pathophysiological analyses of 7 ocular lesions in Spontaneously Diabetic Torii (SDT) fatty rats were performed. First, 8 vascular endothelial growth factor (VEGF) concentrations in vitreous humor, retinal 9 vascular permeability and retinal thickness were measured in SDT fatty rats 10 (Experiment 1). Furthermore, the pharmacological effects of two anti-diabetic drugs, 11 phlorizin and pioglitazone, on retinal lesions were evaluated (Experiment 2). As results, 12 the SDT fatty rats exhibited VEGF increase in vitreous humor at 8 and 16 weeks of age, 13 and both retinal vascular hyperpermeability and retinal thickening at 16 weeks of age. In 14 particular, the layers between the retinal internal limiting membrane and the outer 15 nuclear layer were thickened. Phlorizin treatment from 4 to 16 weeks of age improved 16 hyperglycemia and normalized retinal thickness; however, the effect of pioglitazone on 17 retinal thickness was not strong despite the normalization of hyperglycemia. These data 18 demonstrate that the male SDT fatty rat is a useful model for developing new 19 therapeutic approaches in DME. 20
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Summary 4
Diabetic macular edema (DME) is a major factor contributing to visual disabilities in 5 diabetic patients, and the number of patients is increasing. Animal models play a key 6 role in the development of novel therapies. In this study, pathophysiological analyses of 7 ocular lesions in Spontaneously Diabetic Torii (SDT) fatty rats were performed. First, 8 vascular endothelial growth factor (VEGF) concentrations in vitreous humor, retinal 9 vascular permeability and retinal thickness were measured in SDT fatty rats 10 (Experiment 1). Furthermore, the pharmacological effects of two anti-diabetic drugs, 11 phlorizin and pioglitazone, on retinal lesions were evaluated (Experiment 2). As results, 12 the SDT fatty rats exhibited VEGF increase in vitreous humor at 8 and 16 weeks of age, 13 and both retinal vascular hyperpermeability and retinal thickening at 16 weeks of age. In 14 particular, the layers between the retinal internal limiting membrane and the outer 15 nuclear layer were thickened. Phlorizin treatment from 4 to 16 weeks of age improved 16 hyperglycemia and normalized retinal thickness; however, the effect of pioglitazone on 17 retinal thickness was not strong despite the normalization of hyperglycemia. These data 18 demonstrate that the male SDT fatty rat is a useful model for developing new 19 therapeutic approaches in DME. 20
Introduction 1
Diabetic macular edema (DME) is a frequent finding associated with diabetic 2 retinopathy (DR) and is a major factor contributing to visual disabilities in patients with 3 diabetes mellitus (Cheung et al. 2010) . The current worldwide estimates are 92.6 4 million patients with DR and 20.6 million DME patients, with the number of sufferers 5 expected to rise in the future (Yau et al. 2012) . The relationship between DR and 6 Hemoglobin A1c (HbA1c) was revealed in the landmark Diabetes Control and 7
Complications Trial (DCCT) study (The Diabetes Control and Complications Trial 8
Research Group 1996) . Therefore, sustained lowering of blood glucose levels can 9 prevent the risk of progression of DR and other diabetic complications. As such, 10 numerous anti-diabetic drugs have been developed by pharmaceutical companies and 11 seven different types of agents are now available: sulfonylureas, biguanides, 12 α-glucosidase inhibitors, glinides, thiazolidinediones, incretin related drugs and 13 sodium-glucose cotransporter (SGLT) 2 inhibitors (Takamoto and Kadowaki 2011, 14 Chen et al. 2016) . However, despite the numerous available choices, diabetic 15 complications often develop and lead to both life-threatening and life-altering problems. 16
Many years of diabetes leads to biochemical and molecular abnormalities, such as 17 the production of advanced glycation end-products (AGEs), generation of reactive 18 oxygen species (ROS) and activation of protein kinase C (PKC) followed by cytokines, 19 including vascular endothelial growth factor (VEGF), and chemokine production in 20 retina and retinal capillaries (Das 2016) . 1 VEGF, as a permeable factor, induces the alteration of tight junction proteins that 2 contributes to a breakdown of the blood-retinal barrier (BRB), promotes vascular 3 permeability and causes retinal edema (Kim et al. 2009 , Murakami et al. 2009 ). Hence, 4 neutralizing anti-VEGF antibodies, such as ranibizumab, bevacizumab and VEGF trap, 5 have become standard of care for DME in the past 10 years. However, 25% of DME 6 patients do not respond to anti-VEGF treatment (Singer et al. 2016) . Therefore, the 7 elucidation of the underlying mechanism is highly anticipated. To reveal the mechanism, Fatty (OLETF) rats (Lu et al. 2003) , and Zucker Diabetic Fatty (ZDF) rats (Johnson et 11 al. 2013 ) are often used. However, retinal thickening is not observed in these animals, 12 unlike human DME patients. 13
The Spontaneously Diabetic Torii (SDT) fatty rat was established by introducing the 14 fa allele into the SDT rat genome, and the onset of diabetes is observed at 6 weeks of 15 age (Masuyama et al. 2005) . Recent studies indicate that this model also exhibits 16 various diabetic complications (Katsuda et al. 2015) . In particular, in the retina, the 17 peak latencies of oscillatory potentials in electroretinograms (ERGs) at 16 weeks of age 18 are prolonged when compared with the lean rat, demonstrating retinal dysfunction 19 (Matsui et al. 2008) . In this study, we investigated pathophysiological changes 20 associated with hyperglycemia in the retina of SDT fatty rats. We evaluated VEGF 1 accumulation in the vitreous humor, retinal vascular permeability, retinal thickening 2 (Experiment 1), and the therapeutic effects of anti-diabetic drugs on retinal thickening 3 in the male SDT fatty rat (Experiment 2). 4
5
Materials and Methods 6
Animals 7
Male SDT fa/fa (fatty) rats and age-matched Sprague-Dawley (SD) rats were 8 purchased from CLEA Japan, Inc. (Tokyo, Japan). Rats were housed in a 9 climate-controlled room at a temperature of 23 ± 3°C, humidity of 55 ± 15%, and a 12 h 10 lighting cycle. A powdered basal diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan) 11 and water were provided ad libitum. All experiments received prior approval from the 12 committee for human care and use of animals at our laboratory in accordance with the 13 Standards Relating to the Care and Management of Experimental Animals. 14 15
Biological parameters 16
Body weight and biological parameters were evaluated. Blood samples were 17 collected from the tail vein. Glucose, HbA1c, triglyceride and total cholesterol levels 18
were measured using commercial kits (Roche Diagnostics, Basel, Switzerland) and an 19 automatic analyzer (Hitachi 7180; Hitachi, Tokyo, Japan). Plasma insulin levels were 20 measured using an ELISA kit (Morinaga, Yokohama, Japan). 1 2
Experiment 1 3
VEGF concentration in vitreous humor 4
Animals at 8 and 16 weeks of age were sacrificed under deep isoflurane anesthesia. 5
Both eyes were enucleated, washed with saline three times, and then wiped with cotton 6 to dry. After pricking the eyes near the optic nerve with a 27-gauge needle, 7 approximately 60 μl of the vitreous humor was collected into 0.5 ml Eppendorf tubes 8 and immediately frozen in liquid nitrogen. Samples were thawed on ice and centrifuged 9
at 10000 x g for 5 minutes at 4°C, after which the supernatant was used. VEGF 10 concentrations were measured using a Rat VEGF Quantikine ELISA Kit (R&D Systems 11
Inc., Minneapolis, MN, U.S.A.). 12
13
Retinal vascular permeability 14
Rats were given an intravenous dose of 10 mg/kg of sodium fluorescein. One hour 15 later, blood samples and vitreous humor were collected. After centrifugation (10,000 x g 16 for 5 minutes at 4°C), the fluorescein concentration of the serum samples was measured 17 by using a microplate reader (ARVO-X5 2030. Multilabel Reader; Perkin-Elmer) with 18 excitation at 485 nm and emission at 535 nm. Retinal vascular permeability was 19 calculated by dividing fluorescein concentration of vitreous humor by that of blood 20
plasma. 1 2
Ocular histopathology 3
The eyes were enucleated and fixed in 1% formalin/1.5% glutaraldehyde mix 4 fixative solution, and then embedded in paraffin, sectioned, stained with hematoxylin 5 and eosin (HE), and examined histopathologically. 6 7
Measurement of retinal thickness 8
In the previous report by Toyoda et al., mean retinal thickness at 500, 1000, and 9 1500 µm from the optic nerve disc were almost same (Toyoda et al. 2016) . Therefore, 10 the total retinal thickness in this experiment was defined as the distance between the 11 retinal internal limiting membrane (ILM) and the photoreceptor layer (PL) 500 μm 12 away from the optic nerve disc. The thickness of the ILM of the ganglion cell layer 13 (GCL), the inner plexiform layer (IPL), inner nuclear layer (INL), outer nuclear layer 14 (ONL) and PL were also measured. 15
16
Experiment 2 17
Experiment grouping design for anti-diabetic drugs 18
Based on the biological parameters, SD rats and SDT fatty rats at 4 weeks of age 19 were divided into four subgroups; Group 1 (normal control): SD rats subcutaneously 20 injected with 20% propylene glycol and fed powdered CRF-1 chow; Group 2 (DME 1 vehicle): SDT fatty rats subcutaneously injected with 20% propylene glycol and fed 2 powdered CRF-1 chow; Group 3 (DME pioglitazone): SDT fatty rats subcutaneously 3 injected with 20% propylene glycol and administered 10 mg/kg/day pioglitazone 4 (synthesized at Japan Tobacco Co.) through powdered CRF-1 chow (food admixture); 5 and Group 4 (DME phlorizin): SDT fatty rats subcutaneously injected with 6 150 mg/kg/day phlorizin (Sigma-Aldrich Co., St. Louis, MO, U.S.A.) and fed powdered 7 CRF-1 chow. 8 9
Statistical Analysis 10
All values were expressed as the mean ± standard deviation. If there were 2 groups to 11 compare, an F-test for homogeneity of variance followed by Student's t-test or 12
Aspin-Welch's t-test was performed. To compare the means of the three groups 13 (Experiment 2), Dunnett's test or Steel's test was performed after Bartlett's test was 14 performed to assess the homogeneity of variances. All statistical analyses were 15 performed using Statlight 2000 (Yukms Corp., Tokyo, Japan) statistical software. A 16 P-value < 0.05 was considered statistically significant. 17
18
Results
19
Experiment 1 20
Body weight and blood chemical parameters, such as glucose, insulin, triglyceride 1 (TG) and total cholesterol (TC) levels, are shown in Table 1 . At 8 weeks of age, the 2 SDT fatty rats exhibited obesity, hyperglycemia, hyperinsulinemia and hyperlipidemia. 3
Although hyperglycemia was observed in SDT fatty rats that were 16 weeks of age, 4 body weight, insulin and TG levels showed decreases. 5
The vitreous humor from SD rats and SDT fatty rats were collected. Compared with 6 normal values, the mean vitreous VEGF concentration value in SDT fatty rats was 7 significantly higher at 8 weeks of age (50.5 ± 19.2 pg/ml for SD rats versus 8
200.1 ± 41.9 pg/ml for SDT fatty rats) and showed tendency to increase at 16 weeks of 9 age (9.0 ± 2.7 pg/ml for SD rats versus 28.6 ± 32.6 pg/ml for SDT fatty rats) in Figure  10 1A. Furthermore, the retinal permeability of SDT fatty rats at 16 weeks of age also 11 showed tendency to increase (p value = 0.07) in Figure 1B . 12
The eye specimens from SD rats ( Fig. 2A) and SDT fatty rats (Fig. 2B) were 13 observed under a microscope. The mean values for total retinal thickness, defined as the 14 distance from the ILM to the PL 500 µm away from the optic nerve disc, were measured. 15
The retinas of SDT fatty rats were significantly thicker than that of SD rats in Figure 2C  16 (157.5 ± 19.8 µm for SD rats versus 218.4 ± 16.9 µm for SD rats). The layers between 17 the ILM and the GCL, the IPL, INL and ONL of SDT fatty rats were significantly 18 thicker than those of SD rats. On the other hand, the thickness of the PL in SDT fatty 19 rats was not significant when compared with that in SD rats, as shown in Figure 2D . 20 1
Experiment 2 2
SDT fatty rats were treated from 4 to 16 weeks of age with anti-diabetic drugs, 3 pioglitazone (10 mg/kg/day) or phlorizin (150 mg/kg/day). Pioglitazone significantly 4 increased body weight at 8 and 16 weeks of age and phlorizin at 16 weeks of age 5 ( Figure 3A ). Both drugs strongly reduced plasma glucose levels ( Figure 3B ), HbA1c 6 ( Figure 3C ) and TG levels ( Figure 3E ) at 8 and 16 weeks of age. From 8 to 16 weeks of 7 age, vehicle groups exhibited sharp declines in plasma insulin levels, whereas both 8 treatment groups retained higher levels ( Figure 3D ), indicating the preservation of 9 pancreatic β-cell function. For plasma TC levels, treatment with pioglitazone resulted in 10 a tendency toward decreases and significant decreases at 16 weeks of age ( Figure 3F ) 11 with phlorizin treatment. 12
The total retina of SDT fatty rats was thicker than that of SD rats, and both 13 pioglitazone and phlorizin decreased retinal thickness in Figure 4A . The layers between 14 the ILM and GCL, the IPL, INL and ONL in SDT fatty rats were significantly thicker 15 than those of SD rats and these layers showed a tendency to decrease when treated using 16 either of the drugs in Figure 4B . 17
18
Discussion 19
To reveal the mechanism and develop new therapies, many researchers have 20 investigated animal models. STZ-induced animals are recognized as the most common 1 model and retinal hyperpermeability was reported. Nevertheless, in this model, retinal 2 thickness becomes thinner than control, unlike in human patients (Zhang et al. 2008) . 3
Although the OLETF rat and ZDF rat show morphological changes in the retinal 4 capillaries or pericytes, retinal thickening has unfortunately not been reported (Lu et al. 5 2003 , Johnson et al. 2013 , Lai and Lo 2013 . 6
The SDT rat is a known non-obese type 2 diabetes model and VEGF overexpression, year. Because SDT fatty rat was originally produced by introducing fa gene to SDT rat 13 to accelerate the development of diabetic complications, similar ocular lesions are 14 basically expected between these two strains. However, the effect of aging is quite 15 important for pathophysiology of eyes -actually, SD rats demonstrate spontaneous 16 ocular abnormalities, such as corneal or lenticular opacities, choroidal or retinal atrophy, 17 retinal fold, and hemorrhage increased with greater frequency with increasing age (Ban 18 et al. 2008 , Tomomi 2008 . Therefore, advancing the development of ocular 19 complications is meaningful for studying diabetic retinopathy using experimental 20 animal model. In addition, according to obesity and following insulin resistance, 1 inflammation is found in eyes in SDT fatty rat at older age (Kemmochi et al. 2014) . 2 Also, further studies are needed to unveil the difference of response to various drugs, 3 such as SGLT2 inhibitor, between SDT and SDT fatty rat. 4
The SDT fatty rat is recognized as a diabetes model, and in this study, exhibited 5 severe hyperglycemia from 8 weeks of age followed by VEGF overproduction, retinal 6 vascular hyperpermeability, and retinal thickening. Generally, rapid increases in blood 7 glucose may enhance glycolysis and the diacylglycerol pathway involving PKC 8 activation followed by VEGF production (Xia et al. 2007) . Furthermore, oxidative 9 stress induced by hyperglycemia also causes VEGF production, matrix 10 metalloproteinase (MMP) activation and breakdowns in the BRB (El-Remessy et al. 11 2013). These changes can be one of the reasons of the peak latency in ERGs of male 12 SDT fatty rats at 16 weeks of age (Matsui et al. 2008) . 13
In this study, we have chosen pioglitazone and phlorizin to evaluate the effect of 14 controlling blood glucose level. These drugs are cheap and easy to purchase, and above 15 all, these drugs have already reported to lower blood glucose levels well without any 16 side effects in SDT fatty rats. Interestingly, although the glucose-lowering effect of 17 pioglitazone and phlorizin is the same, pioglitazone could not normalize retinal 18 thickness. Recently, Dennis et al. reported that reductions in serum glucose 19 concentrations with phlorizin treatment led to normalized VEGF concentrations in the 20 retina of STZ-induced rats (Dennis et al. 2015) . Therefore, glucose-lowering effects can 1 contribute to decreases in retinal VEGF expression. 2 Generally, glitazones have side effects, such as edema, which is likely caused by 3 renal sodium retention (Colucciello 2005 , Ryan et al. 2006 , Horita et al. 2015 , and in 4 actual human DME patients, some studies have indicated the adverse effect of 5 pioglitazone (Oshitari et al. 2008 , Idris et al. 2012 . Hence, the effect of pioglitazone 6 must be weakened against the retinal thickness despite plasma glucose normalization. 7
As mentioned above, lowering blood glucose levels normalize VEGF concentrations in 8 retina. On the other hands, pioglitazone causes edema as its side effect. Therefore, we 9 speculate that the imbalance of effect and side effect of pioglitazone may cause different 10 output on retinal thickness between human and SDT fatty rat. Given these facts, SDT 11 fatty rat is a prominent animal model, which enables us to evaluate not only positive 12 effects but also side effects in advance without clinical trials. 13
In summary, we identified an increase in VEGF in vitreous humor, retinal vascular 14 hyperpermeability, and retinal thickening, in particular from the ILM to ONL of SDT 15 fatty rats at 16 weeks of age. Furthermore, the retinal thickening improved with 16 treatment with anti-diabetic drugs, pioglitazone and phlorizin. However, unlike 17 phlorizin, the effect of pioglitazone is not strong despite the normalization of blood 18 glucose levels. Altogether, we confirmed that the male SDT fatty rat is a suitable 19 preclinical model for testing new therapeutic approaches in DME. 20 SDT fatty rats (B, representative example) at 16 weeks of age. The layer in the retina 8 that was 500 m from the optic disc was enlarged. The total retinal thickness (C) and 9 the layer between the ILM (inter limiting membrane) and GCL (ganglion cell layer), the 10 IPL (inner plexiform layer), INL (inner nuclear layer), ONL (outer nuclear layer) and PL 11 represents the mean ± S.D (n=4). **: p < 0.01, significantly different from the control 1 group. #: p < 0.05, ##: p < 0.01, significantly different from the vehicle group. 2 Table 1 . Body weight and serum biochemical parameters 1 
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